| Dr Rusna K Jhita, MD | |
|
18101 Oakwood Blvd, Dearborn, MI 48124-4089 | |
| (313) 436-2577 | |
| (313) 436-2756 |
| Full Name | Dr Rusna K Jhita |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 18101 Oakwood Blvd, Dearborn, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053805200 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4351033808 (Michigan) | Primary |
| Entity Name | Bass Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174253405 PECOS PAC ID: 9032111281 Enrollment ID: O20070201000181 |
News Archive
With a more-is-better mindset common in society, frequent commercials encouraging checks of glycated hemoglobin (HbA1C) levels, and ads for new diabetes medications to lower HbA1C in adults with Type 2 diabetes, Mayo Clinic researchers were not too surprised to find overtesting occurring.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
Universal and annual voluntary testing followed by immediate antiretroviral therapy treatment (irrespective of clinical stage or CD4 count) can reduce new HIV cases by 95% within 10 years, according to new findings based on a mathematical model developed by a group of HIV specialists in WHO.
The recent ruling in the Sottera, Inc. v. Food & Drug Administration case has once again brought the E-Cigarette industry into the spotlight and Green Nicotine Electronic Cigarettes could not be better prepared. Many electronic cigarette companies will have to scramble to prepare for FDA regulation, but Green Nicotine Electronic Cigarettes has been prepared for these types of regulations since 2009.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rusna K Jhita, MD 18101 Oakwood Blvd, Dearborn, MI 48124-4089 Ph: (313) 436-2577 | Dr Rusna K Jhita, MD 18101 Oakwood Blvd, Dearborn, MI 48124-4089 Ph: (313) 436-2577 |
News Archive
With a more-is-better mindset common in society, frequent commercials encouraging checks of glycated hemoglobin (HbA1C) levels, and ads for new diabetes medications to lower HbA1C in adults with Type 2 diabetes, Mayo Clinic researchers were not too surprised to find overtesting occurring.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
Universal and annual voluntary testing followed by immediate antiretroviral therapy treatment (irrespective of clinical stage or CD4 count) can reduce new HIV cases by 95% within 10 years, according to new findings based on a mathematical model developed by a group of HIV specialists in WHO.
The recent ruling in the Sottera, Inc. v. Food & Drug Administration case has once again brought the E-Cigarette industry into the spotlight and Green Nicotine Electronic Cigarettes could not be better prepared. Many electronic cigarette companies will have to scramble to prepare for FDA regulation, but Green Nicotine Electronic Cigarettes has been prepared for these types of regulations since 2009.
› Verified 9 days ago
Peter Stevenson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2100 Monre, Dearborn, MI 48124 Phone: 313-278-3900 | |
Maria F Hayes, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 18181 Oakwood Blvd, Ste 109, Dearborn, MI 48124 Phone: 313-299-6650 Fax: 313-299-6651 | |
David M Magyar, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 18181 Oakwood Blvd, Ste 109, Dearborn, MI 48124 Phone: 313-299-6650 Fax: 313-299-6651 | |
Heba Al Butairi, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 18101 Oakwood Blvd, Ob.gyn Medical Education, Dearborn, MI 48124 Phone: 313-436-2582 | |
Dr. Evan Charles Delancey, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 870-549-2207 | |
Todd Allen, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd, Suite 200, Dearborn, MI 48124 Phone: 313-593-5810 |